Voriconazole Intravenous (IV) Solution bulk supplier for pharma manufacturers

Voriconazole Intravenous (Iv) Solution 200 mg/100 mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Solution

Available Strengths: 200 mg/100 mL

Reference Brands: Vfend(US & EU)

Voriconazole IV inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis essential for fungal cell membranes. It provides broad-spectrum antifungal activity, rapid systemic treatment, and excellent tissue penetration. Benefits include high efficacy against invasive fungi like Aspergillus, making it vital for treating severe fungal infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Voriconazole IV solution is approved in the EU and US for severe fungal infections. In the EU, Pfizer’s Vfend IV is regulated by EMA, backed by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with regulatory dossiers, submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We support efficient market access for voriconazole IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Voriconazole Intravenous (Iv) Solution — third party manufacturing & bulk supply

Voriconazole Intravenous (Iv) Solution 200 mg/100 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Voriconazole Intravenous (Iv) Solution is supplied as Intravenous (IV) Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Voriconazole Intravenous (Iv) Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Voriconazole Intravenous (Iv) Solution →

Back to Listing

Frequently Asked Questions

Voriconazole is used to treat serious fungal infections, particularly invasive aspergillosis, candidemia, esophageal candidiasis, and infections caused by Scedosporium and Fusarium species. It is often prescribed for immunocompromised patients and is known for its broad-spectrum antifungal activity and strong efficacy.

Voriconazole contains the active triazole antifungal compound voriconazole. It is formulated with suitable pharmaceutical excipients designed to enhance absorption, stability, and bioavailability depending on the dosage form.

The main trade name for voriconazole is Vfend, widely marketed in the USA, EU, UK, and other global regions.

Vfend is manufactured by Pfizer. Generic versions of voriconazole are also produced by several GMP-certified manufacturers across different international markets.

The generic name is voriconazole.

The primary brand name is Vfend.

Voriconazole is manufactured in Pfizer’s regulated facilities in the USA and Europe, along with multiple GMP-approved pharmaceutical companies that produce generic voriconazole for global supply.